FDA Designates NDA for AMAG Pharma's (AMAG) Ferumoxytol as Complete; FDA Sets Dec. 30 PDUFA Date
Tweet Send to a Friend
AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that the U.S. FDA has designated the Company's resubmission to the October 2008 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
